Sponsor pipeline

Chongqing Medical University clinical trial pipeline

Get alerts when Chongqing Medical University's trials change

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

4 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 0 with minor changes only.

Notable

GAPA · 68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism: The GAPA Randomized Clinical Trial

Primary endpoint(s) modified

Also in this update: Sponsor changed: Qifu Li to Chongqing Medical University; Trial completed

Chongqing Medical UniversityNot applicable NCT06238232 Registry history of NCT06238232 on ClinicalTrials.gov (opens the registry)

Updated Sep 25, 2026
Notable

Finerenone · Primary Aldosteronism (FAIRY)

Sponsor changed: Qifu Li to Chongqing Medical University

Also in this update: Primary completion date changed from estimate of Jun 1, 2025 to Apr 20, 2026; Trial status changed: Unknown → Completed

Chongqing Medical UniversityPhase 4 NCT06457074 Registry history of NCT06457074 on ClinicalTrials.gov (opens the registry)

Updated Sep 25, 2026
Notable

CONACSS · Chongqing Adrenogenic Autonomic Cortisol Secretion Cohort Study

Recruitment opened

Chongqing Medical UniversityNot specified NCT05743933 Registry history of NCT05743933 on ClinicalTrials.gov (opens the registry)

Updated Sep 24, 2026
Notable

Intensia-Aldo · Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism

Recruitment opened

Chongqing Medical UniversityNot applicable NCT07673445 Registry history of NCT07673445 on ClinicalTrials.gov (opens the registry)

Updated Sep 21, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Not charted: 11 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT ID	Title	Condition	Status	Updated
Not applicable
NCT07673445	Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism	Primary Aldosteronism	Recruiting	2026-09-21
NCT07625007	Shortwave Intervention for Diabetic Peripheral Neuropathy.	Diabetic Peripheral Neuropathy	Recruiting	2026-06-18
NCT07625020	Ultrasound-Guided Nerve Hydrodissection for Diabetic Lower Limb Entrapment Neuropathy	Diabetic Peripheral Neuropathy	Recruiting	2026-06-17
NCT07503509	Physiological Study of High PEEP in Noninvasive Ventilation	Respiratory Failure With Hypoxia	Recruiting	2026-03-31
NCT07298889	High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS	Noninvasive Ventilation	Recruiting	2026-01-07
NCT07700472	Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma	Primary Aldosteronism	Not Yet Recruiting	2026-07-14
Not specified
NCT05743933	Chongqing Adrenogenic Autonomic Cortisol Secretion Cohort Study	Diagnosis	Recruiting	2026-09-24
NCT05069441	Prediction of Extubation Failure: A Multicenter Prospective Observational Study	Mechanical Ventilation	Recruiting	2026-03-23
NCT05974904	Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study	Metabolic Dysfunction-associated Fatty Liver Disease	Recruiting	2025-02-12
NCT03224312	Chongqing Primary Aldosteronism Study	Primary Aldosteronism	Recruiting	2023-09-06
NCT03692884	Chongqing Diabetes Registry Study	Diabetes Mellitus	Recruiting	2023-09-06

Disease areas by active trials

Diabetes (1) · NASH / MASH (1)

Get alerts when Chongqing Medical University's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.

Start monitoring free